PubMed

Vascular calcification: the killer of patients with chronic kidney disease.

Mizobuchi M, Towler D, Slatopolsky E.

J Am Soc Nephrol. 2009 Jul;20(7):1453-64. Epub 2009 May 28.PMID: 19478096 [PubMed - indexed for MEDLINE]Related articles

Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells.

Mizobuchi M, Ritter CS, Krits I, Slatopolsky E, Sicard G, Brown AJ.

J Bone Miner Res. 2009 Jul;24(7):1173-9.PMID: 19257819 [PubMed - indexed for MEDLINE]Related articles

Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification.

Tokumoto M, Mizobuchi M, Finch JL, Nakamura H, Martin DR, Slatopolsky E.

Am J Nephrol. 2009;29(6):582-91. Epub 2009 Jan 15.PMID: 19145073 [PubMed - indexed for MEDLINE]Related articles

Relation of serum fetuin-A levels to coronary artery calcium in African-American patients on chronic hemodialysis.

Zheng S, de Las Fuentes L, Bierhals A, Ash-Bernal R, Spence K, Slatopolsky E, Davila-Roman VG, Delmez J.

Am J Cardiol. 2009 Jan 1;103(1):46-9. Epub 2008 Oct 30.PMID: 19101228 [PubMed - indexed for MEDLINE]Related articles

Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats.

Husain K, Ferder L, Mizobuchi M, Finch J, Slatopolsky E.

Am J Nephrol. 2009;29(5):465-72. Epub 2008 Nov 26.PMID: 19033720 [PubMed - indexed for MEDLINE]Related articles

Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism.

Arcidiacono MV, Cozzolino M, Spiegel N, Tokumoto M, Yang J, Lu Y, Sato T, Lomonte C, Basile C, Slatopolsky E, Dusso AS.

J Am Soc Nephrol. 2008 Oct;19(10):1919-28. Epub 2008 Jun 25.PMID: 18579641 [PubMed - indexed for MEDLINE]Related articlesFree article

Vitamin D analogs: therapeutic applications and mechanisms for selectivity.

Brown AJ, Slatopolsky E.

Mol Aspects Med. 2008 Dec;29(6):433-52. Epub 2008 May 1. Review.PMID: 18554710 [PubMed - indexed for MEDLINE]Related articles

Clinical consequences and management of hypomagnesemia.

Martin KJ, González EA, Slatopolsky E.

J Am Soc Nephrol. 2009 Nov;20(11):2291-5. Epub 2008 Jan 30.PMID: 18235082 [PubMed - in process]Related articles

EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.

Arcidiacono MV, Sato T, Alvarez-Hernandez D, Yang J, Tokumoto M, Gonzalez-Suarez I, Lu Y, Tominaga Y, Cannata-Andia J, Slatopolsky E, Dusso AS.

J Am Soc Nephrol. 2008 Feb;19(2):310-20. Epub 2008 Jan 23.PMID: 18216322 [PubMed - indexed for MEDLINE]Related articlesFree article

Destabilization of parathyroid hormone mRNA by extracellular Ca2+ and the calcimimetic R-568 in parathyroid cells: role of cytosolic Ca and requirement for gene transcription.

Ritter CS, Pande S, Krits I, Slatopolsky E, Brown AJ.

J Mol Endocrinol. 2008 Jan;40(1):13-21.PMID: 18096993 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential effects of vitamin D receptor activators on vascular calcification in uremic rats.

Mizobuchi M, Finch JL, Martin DR, Slatopolsky E.

Kidney Int. 2007 Sep;72(6):709-15. Epub 2007 Jun 27.PMID: 17597697 [PubMed - indexed for MEDLINE]Related articles

Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

Mizobuchi M, Morrissey J, Finch JL, Martin DR, Liapis H, Akizawa T, Slatopolsky E.

J Am Soc Nephrol. 2007 Jun;18(6):1796-806. Epub 2007 May 18.PMID: 17513326 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.

Slatopolsky E, Finch JL, Brown AJ, Ritter CS, Mizobuchi M, Plum LA, Clagett-Dame M, Sicinski RR, DeLuca HF.

J Bone Miner Res. 2007 May;22(5):686-94.PMID: 17444814 [PubMed - indexed for MEDLINE]Related articles

Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.

Brown AJ, Slatopolsky E.

Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):134-44. Review.PMID: 17237840 [PubMed - indexed for MEDLINE]Related articles

Molecular basis of parathyroid hyperplasia.

Dusso AS, Arcidiacono MV, Sato T, Alvarez-Hernandez D, Yang J, Gonzalez-Suarez I, Tominaga Y, Slatopolsky E.

J Ren Nutr. 2007 Jan;17(1):45-7. Review. No abstract available. PMID: 17198931 [PubMed - indexed for MEDLINE]Related articles

Pathogenic mechanisms for parathyroid hyperplasia.

Dusso AS, Sato T, Arcidiacono MV, Alvarez-Hernandez D, Yang J, Gonzalez-Suarez I, Tominaga Y, Slatopolsky E.

Kidney Int Suppl. 2006 Jul;(102):S8-11.PMID: 16810310 [PubMed - indexed for MEDLINE]Related articles

25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.

Ritter CS, Armbrecht HJ, Slatopolsky E, Brown AJ.

Kidney Int. 2006 Aug;70(4):654-9. Erratum in: Kidney Int. 2006 Sep;70(6):1190. PMID: 16807549 [PubMed - indexed for MEDLINE]Related articles

Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.

Joist HE, Ahya SN, Giles K, Norwood K, Slatopolsky E, Coyne DW.

Clin Nephrol. 2006 May;65(5):335-41.PMID: 16724654 [PubMed - indexed for MEDLINE]Related articles

Progressive accumulation of lanthanum in the liver of normal and uremic rats.

Slatopolsky E, Liapis H, Finch J.

Kidney Int. 2005 Dec;68(6):2809-13.PMID: 16316357 [PubMed - indexed for MEDLINE]Related articles

Pathogenesis of vascular calcification in chronic kidney disease.

Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E.

Kidney Int. 2005 Aug;68(2):429-36. Review.PMID: 16014020 [PubMed - indexed for MEDLINE]Related articles

A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease.

Cozzolino M, Lu Y, Sato T, Yang J, Suarez IG, Brancaccio D, Slatopolsky E, Dusso AS.

Am J Physiol Renal Physiol. 2005 Nov;289(5):F1096-102. Epub 2005 Jul 5.PMID: 15998841 [PubMed - indexed for MEDLINE]Related articlesFree article

Vitamin D.

Dusso AS, Brown AJ, Slatopolsky E.

Am J Physiol Renal Physiol. 2005 Jul;289(1):F8-28. Review.PMID: 15951480 [PubMed - indexed for MEDLINE]Related articlesFree article

Acute regulation of parathyroid hormone by dietary phosphate.

Martin DR, Ritter CS, Slatopolsky E, Brown AJ.

Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E729-34. Epub 2005 May 24.PMID: 15914507 [PubMed - indexed for MEDLINE]Related articlesFree article

Calcium, phosphorus and vitamin D disorders in uremia.

Slatopolsky E, Brown A, Dusso A.

Contrib Nephrol. 2005;149:261-71. Review.PMID: 15876849 [PubMed - indexed for MEDLINE]Related articles

[Effects of intravenous and oral OCT on secondary hyperparathyroidism in dogs with chronic renal failure]

Takahashi F, Yorozu K, Kawata Y, Kitamura H, Chiba N, Kubodera N, Slatopolsky E.

Clin Calcium. 2002 Jun;12(6):741-8. Japanese. PMID: 15775360 [PubMed]Related articles

[Renal failure and vitamin D]

Brown AJ, Dusso AS, Slatopolsky E.

Clin Calcium. 2002 Jun;12(6):711-23. Japanese. PMID: 15775356 [PubMed]Related articles

Pathogenesis of parathyroid hyperplasia in renal failure.

Cozzolino M, Brancaccio D, Gallieni M, Galassi A, Slatopolsky E, Dusso A.

J Nephrol. 2005 Jan-Feb;18(1):5-8.PMID: 15772917 [PubMed - indexed for MEDLINE]Related articles

Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism.

Akizawa T, Ohashi Y, Akiba T, Suzuki M, Nishizawa Y, Ogata E, Slatopolsky E, Kurokawa K.

Ther Apher Dial. 2004 Dec;8(6):480-91.PMID: 15663548 [PubMed - indexed for MEDLINE]Related articles

1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure.

Dusso A, Cozzolino M, Lu Y, Sato T, Slatopolsky E.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):507-11. Review.PMID: 15225829 [PubMed - indexed for MEDLINE]Related articles

Parathyroid cells cultured in collagen matrix retain calcium responsiveness: importance of three-dimensional tissue architecture.

Ritter CS, Slatopolsky E, Santoro S, Brown AJ.

J Bone Miner Res. 2004 Mar;19(3):491-8.PMID: 15040838 [PubMed - indexed for MEDLINE]Related articles

Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy.

Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, Malluche HH, McCarthy JT, Massry SG, Mehls O, Salusky IB, Silver JM, Smogorzewski MT, Slatopolsky EM, McCann L; Bone Turnover Work Group.

Am J Kidney Dis. 2004 Mar;43(3):558-65. Review. No abstract available. PMID: 14981615 [PubMed - indexed for MEDLINE]Related articles

Vitamin D receptor and analogs.

Dusso AS, Thadhani R, Slatopolsky E.

Semin Nephrol. 2004 Jan;24(1):10-6. Review.PMID: 14730505 [PubMed - indexed for MEDLINE]Related articles

Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.

Cozzolino M, Staniforth ME, Liapis H, Finch J, Burke SK, Dusso AS, Slatopolsky E.

Kidney Int. 2003 Nov;64(5):1653-61.PMID: 14531797 [PubMed - indexed for MEDLINE]Related articles

Pathogenesis and treatment of renal osteodystrophy.

Slatopolsky E, Gonzalez E, Martin K.

Blood Purif. 2003;21(4-5):318-26. Review.PMID: 12944733 [PubMed - indexed for MEDLINE]Related articles

New developments in hyperphosphatemia management.

Slatopolsky E.

J Am Soc Nephrol. 2003 Sep;14(9 Suppl 4):S297-9. Review. No abstract available. PMID: 12939384 [PubMed - indexed for MEDLINE]Related articlesFree article

[Calcimimetic agents in the treatment of hyperparathyroidism secondary to chronic renal failure]

Negri AL, Slatopolsky EA.

Medicina (B Aires). 2003;63(2):165-71. Review. Spanish. PMID: 12793088 [PubMed - indexed for MEDLINE]Related articles

Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.

Slatopolsky E, Cozzolino M, Lu Y, Finch J, Dusso A, Staniforth M, Wein Y, Webster J.

Kidney Int. 2003 Jun;63(6):2020-7.PMID: 12753289 [PubMed - indexed for MEDLINE]Related articles

New vitamin D analogs.

Slatopolsky E, Finch J, Brown A.

Kidney Int Suppl. 2003 Jun;(85):S83-7. Review.PMID: 12753273 [PubMed - indexed for MEDLINE]Related articles

Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function.

Ritter CS, Martin DR, Lu Y, Slatopolsky E, Brown AJ.

J Bone Miner Res. 2002 Dec;17(12):2206-13.PMID: 12469914 [PubMed - indexed for MEDLINE]Related articles

Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients.

Coyne DW, Grieff M, Ahya SN, Giles K, Norwood K, Slatopolsky E.

Am J Kidney Dis. 2002 Dec;40(6):1283-8.PMID: 12460048 [PubMed - indexed for MEDLINE]Related articles

Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure.

Takahashi F, Furuichi T, Yorozu K, Kawata S, Kitamura H, Kubodera N, Slatopolsky E.

Nephrol Dial Transplant. 2002;17 Suppl 10:46-52.PMID: 12386269 [PubMed - indexed for MEDLINE]Related articles

A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic rats.

Hirata M, Endo K, Ohkawa H, Kumaki K, Kubodera N, Slatopolsky E, Kurokawa K, Fukagawa M.

Nephrol Dial Transplant. 2002;17 Suppl 10:37-40.PMID: 12386267 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study.

Akizawa T, Suzuki M, Akiba T, Nishizawa Y, Ohashi Y, Ogata E, Slatopolsky E, Kurokawa K.

Nephrol Dial Transplant. 2002;17 Suppl 10:28-36.PMID: 12386266 [PubMed - indexed for MEDLINE]Related articlesFree article

Vitamin D analogues for secondary hyperparathyroidism.

Brown AJ, Dusso AS, Slatopolsky E.

Nephrol Dial Transplant. 2002;17 Suppl 10:10-9. Review.PMID: 12386264 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats.

Slatopolsky E, Cozzolino M, Finch JL.

Kidney Int. 2002 Oct;62(4):1277-84.PMID: 12234297 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.

Cozzolino M, Dusso AS, Liapis H, Finch J, Lu Y, Burke SK, Slatopolsky E.

J Am Soc Nephrol. 2002 Sep;13(9):2299-308.PMID: 12191974 [PubMed - indexed for MEDLINE]Related articlesFree article

1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor.

Cordero JB, Cozzolino M, Lu Y, Vidal M, Slatopolsky E, Stahl PD, Barbieri MA, Dusso A.

J Biol Chem. 2002 Oct 11;277(41):38965-71. Epub 2002 Aug 13.PMID: 12181310 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport.

Brown AJ, Finch J, Slatopolsky E.

J Lab Clin Med. 2002 May;139(5):279-84.PMID: 12032488 [PubMed - indexed for MEDLINE]Related articles

Control of uremic bone disease: role of vitamin D analogs.

Slatopolsky E, Dusso A, Brown AJ.

Kidney Int Suppl. 2002 May;(80):143-8. Review. No abstract available. PMID: 11982828 [PubMed - indexed for MEDLINE]Related articles

Hyperplasia of the parathyroid gland without secondary hyperparathyroidism.

Takahashi F, Denda M, Finch JL, Brown AJ, Slatopolsky E.

Kidney Int. 2002 Apr;61(4):1332-8.PMID: 11918740 [PubMed - indexed for MEDLINE]Related articlesFree article